RobertA.BurgerMD

Obstetrics & Gynecology • Philadelphia, PA

Gynecologic Oncology

Director of Clinical Research and Gynecologic Oncology Fellowship Program, University of Pennsylvania

Join to view full profile

Dr. Burger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Burger's full profile

Already have an account?

Office
3400 Civic Center Blvd
Philadelphia, PA 19104
Phone+1 215-662-3318

Fax+1 215-349-5680

Education & Training

University of California (Irvine)Fellowship, Gynecologic Oncology, 1992 - 1996
University of Pennsylvania Health SystemResidency, Obstetrics and Gynecology, 1988 - 1992
New York University School of MedicineClass of 1988
Harvard UniversityAB, Biochemistry, Cum Laude, 1980 - 1984

Certifications & Licensure

CA State Medical License 1991 - 2021
PA State Medical License 1991 - 2020
NV State Medical License 1998 - 2003
TX State Medical License 1997 - 2000

Awards, Honors, & Recognition

Philadelphia Magazine Castle Connolly, 2012-2014
America's Top Doctors Castle Connolly, 2012-2014
America's Top Doctors for Cancer Castle Connolly, 2012-2013
Super Doctor SuperDoctors.com
Fellow (FACS) American College of Surgeons
Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Join now to see all

Clinical Trials

Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
Active, not recruiting
Phase 3
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer Start of enrollment: 2012 Jan 09
Completed
Phase 3
Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer Start of enrollment: 2014 Mar 17
Active, not recruiting
Phase 2, Phase 3
A Phase 1b Study of OMP-305B83 Plus Paclitaxel in Subjects With Ovarian, Peritoneal or Fallopian Tube Cancer Start of enrollment: 2016 Dec 01
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

1 citations
Phase I and Randomized Phase II Study of Ruxolitinib With Frontline Neoadjuvant Therapy in Advanced Ovarian Cancer: An NRG Oncology Group Study.
Charles N Landen, Ronald J Buckanovich, Michael W Sill, Robert S Mannel, Joan L Walker
Journal of Clinical Oncology. 2024-07-20
Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/EN...
Bhavana Pothuri, Sileny Han, Dana M Chase, Florian Heitz, Robert A Burger
Gynecologic Oncology. 2024-05-01
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncolo...
Robert F Ozols, Brian N Bundy, Benjamin E Greer, Jeffrey M Fowler, Daniel Clarke-Pearson
Journal of Clinical Oncology. 2023-09-01

Grant Support

Angiogenesis Targeted Therapeutics Of Ovarian CancerNational Cancer Institute2001–2006
Core--Clinical Research OfficeNational Cancer Institute2002

Professional Memberships

American College of Surgeons - ACS
Member